Central nervous system (cns) cancer – pipeline review, h2 2012
1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Central Nervous System (CNS) Cancer – Pipeline Review, H2
2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Central Nervous System (CNS) Cancer - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline. This report
provides information on the therapeutic development for Central Nervous System
(CNS) Cancer, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Central Nervous System (CNS) Cancer. Central Nervous System
(CNS) Cancer - Pipeline Review, Half Year is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Central Nervous System (CNS)
Cancer.
2. - A review of the Central Nervous System (CNS) Cancer products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Central Nervous System (CNS) Cancer.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 8
List of Figures 14
Introduction 15
Global Markets Direct Report Coverage 15
Central Nervous System (CNS) Cancer Overview 16
Therapeutics Development 17
An Overview of Pipeline Products for Central Nervous System (CNS) Cancer 17
Central Nervous System (CNS) Cancer Therapeutics under Development by
Companies 19
Central Nervous System (CNS) Cancer Therapeutics under Investigation by
Universities/Institutes 30
Late Stage Products 43
Comparative Analysis 43
Mid Clinical Stage Products 44
Comparative Analysis 44
Early Clinical Stage Products 45
Comparative Analysis 45
Discovery and Pre-Clinical Stage Products 46
Comparative Analysis 46
Central Nervous System (CNS) Cancer Therapeutics – Products under Development
by Companies 47
Central Nervous System (CNS) Cancer Therapeutics – Products under Investigation
3. by Universities/Institutes 60
Companies Involved in Central Nervous System (CNS) Cancer Therapeutics
Development 102
Genzyme Corporation 102
Boehringer Ingelheim GmbH 103
F. Hoffmann-La Roche Ltd. 104
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012
Respiratory Depression – Pipeline Review, H2 2012
Metastatic Cancer – Pipeline Review, H2 2012
Viral Infections – Pipeline Review, H2 2012
Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
Gastrointestinal Tract Cancer – Pipeline Review, H2 2012
Diabetes – Pipeline Review, H2 2012
4. Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012
Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
Malaria – Pipeline Review, H2 2012
Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012
Dermatitis – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com